Our Solutions

About Us

Altasciences is a forward-thinking, mid-size contract research organization offering biopharmaceutical companies of all sizes a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept, including bioanalysis and research services that encompass the full spectrum of early drug development.

A message from our CEO

Imagine partnering with a team that you trust and telling your story once. Imagine a world where everyone and every project is of equal importance. Just imagine…

Our Story

For over 25 years, we have been integrating into our clients’ projects to help them move from one milestone to the next. Working seamlessly as an extension of your process and your team, we stay focused on your success — moving in unison to deliver big impact with a personal touch.

Our full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics and data management, all of which can be tailored to your specific requirements.

Our shared goal: to help you make educated, faster and more complete early drug development decisions — to speed you to proof of concept and beyond.

Our Unique Structure

Altasciences is structured to provide an integrated end-to-end solution, from lead candidate selection to proof of concept — making the process seamless for you as you move from one milestone to the next.

Our Unique Structure graphic

Our Purpose

Our purpose is to help you research and develop potentially life-saving therapeutics — and get you there faster.

Our Facilities

image
1200 Beaumont Avenue,
Montreal, Québec H3P 3P1
Canada

Altasciences has five strategically placed research facilities in North America. Our three clinics include over 600 beds, an adaptive clinical pharmacology unit for healthy normal participant and patient population studies, as well as a smoking evaluation facility with a controlled ventilation indoor smoking/vaping room.

Our preclinical research site is a 210,000-square-foot, purpose-built facility, where we conduct comprehensive regulatory safety testing, bioanalysis, and other research support services in a wide range of species for both small and large molecule drug development.

We have over 40,000 square feet of bioanalytical laboratory space, with over 100 specialized analysts available 24/7, depending on program needs. We use the latest equipment and advanced methods to support our capacity to process over 60,000 study samples per month.

Our Origins

Our Executive Team

Chris Perkin Chief Executive Officer

Chris became CEO of Altasciences in 2010. He began his career at Huntingdon Life Sciences in England in 1975 as a toxicologist. He served as Section Head for preclinical development at Beecham Pharmaceuticals, as COO for CTBR Bio-Research in Montreal and then as SVP for Charles River Laboratories, responsible for seven preclinical facilities in the U.S., Canada, and China.

BS in Biology

View Linkedin Profile

Catherine Konidas Chief Commercial Officer

Cathy joined us in 2010 with the mandate of transforming our commercial offering to cater to the expanding innovator market, and now oversees our commercial strategy, including M&A activity. She started her career at CTBR Bio-Research Inc. (now Charles River Laboratories) and served as Senior Site Director of its Montreal facility.

BA in Psychology, MBA

View Linkedin Profile

Dr. Bradley D. Vince President & Medical Director, Clinical Services, Kansas City

Dr. Vince founded Vince & Associates Clinical Research in 2001, which became part of Altasciences in 2013. In 2015, he was named as one of the 100 Most Inspiring People in the Life Sciences industry by PharmaVOICE magazine. Widely published, he has participated in over 600 clinical studies, including serving as Principal Investigator on studies funded by the National Institute on Drug Abuse, U.S. FDA, and the Department of Defense.

BA in Biology, Doctor of Osteopathic Medicine

View Linkedin Profile

Steve Mason Executive Vice President, Site Operations

Steve is responsible for all of our preclinical and clinical pharmacology sites. He started as a toxicologist for Huntingdon Life Sciences. At CTBR Bio-Research (now Charles River Laboratories) in Montreal, he built the Safety Pharmacology Department, and then moved to China to establish the Charles River Shanghai preclinical facility, which became the first non-clinical facility in China to be certified as OECD GLP compliant. He joined WuXi AppTec in Suzhou, China, as VP of Preclinical Services, before coming to Altasciences in 2014.

BS in Biological Sciences, MS in Toxicology

View Linkedin Profile

Marie-Hélène Raigneau Executive Vice President, Research Services

Marie-Hélène oversees all of our Research Services, including Data Management, Biostatistics, Project Management, and Medical Writing. She started her career as a Business Development Manager at Future Electronics. At Charles River Laboratories, she rose to become Global Director of Marketing, before joining Altasciences in 2012.

BA in Psychology, Exec MBA

View Linkedin Profile

David Grégoire Vice President Compliance and Regulatory Affairs

David started his career in 2000 as a Quality Assurance Inspector at CTBR Bio-Research (now Charles River Laboratories). At Pharmascience, he developed and implemented a GxP quality system for both bioanalytical and clinical operations. David has been a member of the Board of Directors of the Canadian Chapter of the Society of Quality Assurance, and served as VP and then President. He joined Altasciences in 2012.

BS in Biology

View Linkedin Profile

Julie-Ann Cabana Vice President, Marketing and Commercial Integration

Julie-Ann joined Altasciences in 2014 to lead business development for our Kansas City site’s operations. In 2016, she was promoted to Vice President, Business Development and in 2017, was appointed to her current position. She began her career in 1998 at Origenix Technologies, a biotech company in Montreal. In 2003, she moved to CTBR Bio-Research (now Charles River Laboratories) where she progressed to Head of Marketing. In 2008, she was seconded to China as Director of Business Development for Charles River Laboratories Shanghai, and then served as Head of Global Marketing for the Charles River Laboratories Preclinical Division. In 2011, she joined WuXi AppTec in Suzhou, China, as Executive Director of Business Development for Preclinical Services, managing staff in China and the U.S.

BS in Exercise Science (Kinesiology), MBA

View Linkedin Profile

Robert Sabelli Vice-President, Business Development

Robert oversees all of our business development activities. He joined Altasciences in 2012, focusing initially on the growth of our bioanalysis business. Prior, he worked at Charles River Laboratories as a Regulatory Inspector, where he oversaw the Bioanalytical Preclinical segment and managed government audits. He also spearheaded the training and process development programs for the Quality Assurance departments in several site locations. When he joined Altasciences, he transitioned to Business Development, with responsibilities that included key global account oversight.

BS in Physiology, Graduate Diploma in Business Administration

View Linkedin Profile

Mariano Rodriguez Executive Vice President and Chief Financial Officer

Mariano started his career with Ernst & Young in 1991 before joining Phoenix International as Global Director of Finance where he completed eight acquisitions. Subsequently, he held a number of Chief Financial Officer positions with various companies, including Galileo Genomics, Neurochem, and GFI Solutions. Most recently, Mariano was the Chief Operating Officer and Chief Financial Officer for Klox Technologies. He joined Altasciences in 2018.

B. Commerce, Graduate Degree in Public Accountancy, CPA CA, CPA USA

View Linkedin Profile

Awards

Recognized by the industry, Altasciences has the leadership, scientific, and operational excellence you need to move your programs forward from lead candidate selection to proof of concept.

Our clients

We partner with biotech and pharmaceutical companies of every size and spend, from startups to global leaders. Our client portfolio is deep, international, diverse — and working at the forefront of medical science.

Social Responsibility

Our people take pride in engaging in the communities where we work and live. Initiatives include Dare to Give breast cancer fundraising, our school supplies campaign, Holiday gift drives for kids, food and winter clothing drives, as well as other ways of giving back. We reflect our passion, commitment, and dedication in everything we do, from our community involvement to our work.

Commitment To Participants

We value the people who participate in our clinical trials and contribute to advancing medical science. We, in turn, provide a safe, comfortable, and caring study environment. We treat all our participants respectfully, with transparency and openness, at the initial recruiting and screening process, and throughout the trial period.

Focus On Animal Welfare

We maintain an unwavering focus on the welfare of the laboratory animals in our care. Our entire preclinical staff is trained in laboratory animal care and focused on animal welfare and environmental enrichment—embracing compassion, sensitivity and adherence to regulatory guidelines.

Our Commitment to Animal Welfare

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.

ASK AN EXPERT

Thank you.

We have received your message and will contact you shortly.

Success